U.S. Gas Utilities Stock News

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Tetra Tech...

Tyson Foods, Inc.'s ( NYSE:TSN ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...

From what we can see, insiders were net buyers in Vivani Medical, Inc.'s ( NASDAQ:VANI ) during the past 12 months...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Shareholders in Element Solutions Inc ( NYSE:ESI ) may be thrilled to learn that the analysts have just delivered a...

L.B. Foster Company's ( NASDAQ:FSTR ) recent soft profit numbers didn't appear to worry shareholders, as the stock...

Some AutoNation, Inc. ( NYSE:AN ) shareholders may be a little concerned to see that the Senior VP & Chief Accounting...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Last week, you might have seen that Chevron Corporation ( NYSE:CVX ) released its first-quarter result to the market...

Wintrust Financial Corporation ( NASDAQ:WTFC ) is about to trade ex-dividend in the next two days. The ex-dividend date...

A week ago, Ironwood Pharmaceuticals, Inc. ( NASDAQ:IRWD ) came out with a strong set of quarterly numbers that could...

Shareholders in Ionis Pharmaceuticals, Inc. ( NASDAQ:IONS ) may be thrilled to learn that the analysts have just...

Shareholders might have noticed that Nektar Therapeutics ( NASDAQ:NKTR ) filed its quarterly result this time last...

Unsurprisingly, Illumina, Inc.'s ( NASDAQ:ILMN ) stock price was strong on the back of its healthy earnings report. We...

A week ago, Callaway Golf Company ( NYSE:CALY ) came out with a strong set of quarterly numbers that could potentially...

Cencora, Inc. ( NYSE:COR ) is about to trade ex-dividend in the next three days. The ex-dividend date occurs one day...

Over the past year, insiders sold US$67k worth of Sypris Solutions, Inc. ( NASDAQ:SYPR ) stock at an average price of...

Some Bank of America Corporation ( NYSE:BAC ) shareholders may be a little concerned to see that insider Geoffrey...

In early May 2026, PTC Therapeutics reported first-quarter revenue of US$272.55 million versus US$1.18 billion a year earlier, swinging from net income of US$866.56 million to a net loss of US$2.81 million while still beating analyst expectations on both revenue and earnings per share. The company also released positive 24-month interim data for Huntington’s disease therapy votoplam and raised its 2026 product revenue guidance, underscoring how a strong Sephience launch and advancing...

Southside Bancshares (SBSI) drew fresh attention after reporting first quarter 2026 results and affirming a quarterly dividend of $0.36 per share, pairing earnings information with a continued cash return to shareholders. See our latest analysis for Southside Bancshares. The recent first quarter update and confirmed dividend come after a steadily improving share price. The 1 month share price return was 5.12% and the year to date share price return was 10.51%, alongside a 1 year total...

Q1 earnings spark fresh interest in Lincoln Electric Holdings (LECO) Lincoln Electric Holdings (LECO) is back on investor radar after reporting first quarter sales of US$1,121.43 million and net income of US$136.38 million, both above the prior year period. See our latest analysis for Lincoln Electric Holdings. The earnings beat comes after a mixed share price run, with the stock up 11.22% year to date and delivering a 40.97% total shareholder return over one year. However, the 90 day share...

Ryerson Holding Corporation recently reported past first-quarter 2026 results, with sales rising to US$1,566.5 million and net income reaching US$4.5 million, alongside a return to positive earnings per share from continuing operations. On the same day, the company also filed a US$50.22 million shelf registration for 1,800,000 common shares tied to an ESOP-related offering, underscoring its use of equity for employee benefit plans. We will now examine how Ryerson’s return to profitability...

Taysha Gene Therapies (TSHA) has reaffirmed FDA alignment on the Biologics License Application pathway for TSHA-102, including pivotal trial design and the potential use of a six month interim analysis for approval. See our latest analysis for Taysha Gene Therapies. The reaffirmed FDA pathway comes after a run in the stock, with a 30 day share price return of 45.95% and a 1 year total shareholder return of 217.62%. This signals strong momentum despite recent earnings losses and ongoing cash...